Inferium and Segmind Join Forces to Democratize Access to Advanced AI Models

Inferium, the pioneer ML-driven intelligent store and aggregator for AI inference, and Segmind, the pioneer in AI model development, today announced a strategic partnership to make cutting-edge AI models more accessible and usable for the global AI community.

Key Highlights of the Partnership:

- Expanded Model Access: Segmind's advanced AI models, including SegMoE, SSD-1B, and Segmind-Vega and more, will be seamlessly integrated into Inferium's platform upon launch.

- Co-Marketing and Collaboration: Both companies will actively promote the partnership and collaborate on initiatives to drive awareness and adoption of these powerful models

- Community-Driven Improvement: Inferium will collect and share user feedback with Segmind to continuously enhance the models.

- Free Inference Testing: Inferium will provide Segmind with a period of free inference testing to further support this collaboration, demonstrating a commitment to the partnership and fostering innovation within the AI ecosystem

"We are thrilled to partner with Segmind," said Tristan, CEO at Inferium. "Their models are highly sought-after in the AI community, and this collaboration enables us to offer our users access to cutting-edge AI capabilities. This is a significant step towards democratizing AI and making it accessible to a wider audience."

Steve Lee, Chief Operating Officer at Segmind, added, "Inferium's platform is an ideal showcase for our AI models. We believe that this partnership will not only increase the visibility and adoption of our models but also provide valuable feedback that will help us refine and improve them further."

This partnership marks a significant milestone in the AI landscape, combining Inferium's expertise in AI inference with Segmind's prowess in AI model development. Together, they are poised to drive innovation and accessibility in the AI domain, ultimately benefiting the entire AI community.

Source:

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.